TOP STORIES
The acquisition aids in the expansion of the Astellas Focus Area approach, which involves the creation of medicines for diseases with high unmet medical needs by identifying combinations of biology, therapeutic modality and technology based on emerging science.
/ read more /
The new 50,000-square-foot facility will create 200 new jobs and accelerate commercialization of gene and cell therapies.
/ read more /
|
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
Industry News
Expert poll highlights strength of US pharma sector and advances by emerging markets.
/ read more /
Iontas has entered into a collaboration agreement with Adaptate Biotherapeutics for the generation and optimization of antibodies for novel immune-oncology targets.
/ read more /
MORE INDUSTRY NEWS
|
|
| |
|
|
ADVERTISEMENT
Biopharma N-Glycan Analysis Resource Center
An online resource with useful tools and practical information to find out more about Biopharma N-Glycan Analysis. The site provides useful webcasts, videos, application notes, posters, and more.
Learn More »  |
Regulatory News
The app, CURE ID, is designed to allow the clinical community to report their experiences treating infectious diseases with novel uses of existing FDA-approved drugs.
/ read more /
A NASEM report stresses the importance of information sharing by biopharma companies and cooperation among regulatory authorities.
/ read more /
More Regulatory News
|
|
|
|
|
advertisement 
|
|
|
|
|
|
Biopharma News
Data released by the Cell and Gene Therapy Catapult (CGT Catapult) have shown that demands for specialist skills and investment in the cell and gene therapy industry in the United Kingdom are set to increase in the near future.
/ read more /
CPI has partnered with ImmunoBiology (ImmBio) for the development of a heat-stabilized formulation of a mutli-antigen vaccine candidate against Pneumococcal diseases.
/ read more /
MORE BIOPHARMA NEWS
|
|
|
Supplier News
The new Technology Excellence Center, located in Boston, MA, will further the company’s presence in the United States biopharma drug development landscape.
/ read more /
GE Healthcare Life Sciences and Guangzhou Development District Investment Promotion Bureau have signed an agreement to jointly establish a training center for biopharmaceutical professionals.
/ read more /
MORE SUPPLIER NEWS
|
|
FEATURED TOPICS |
|
MANUFACTURING
Limitations in traditional flu vaccine manufacturing methods underline the need for shifting to modern technologies.
/ read more /
|
|
|
|
|
ANALYTICS
Developing an effective bioassay is crucial for determining the potency of a drug substance or finished drug product. This article gives an overview of how to avoid most problems associated with correct bioassay development.
/ read more /
|
|
|
|
|
QUALITY
With as many as 40 different pharmacopoeias published globally, understanding the origins and purpose of these guidelines is imperative. This article, the third in a series, examines the history and evolution of the pharmacopoeias and the particular challenges that must be overcome to achieve harmonization among the pharmacopoeias.
/ read more /
|
|
|
|
Events
December 9–11, 2019
January 15-16, 2020
February 18–20, 2020
more events
|
|
|
eBook
|
The editors examine the technology, practices, and regulatory approval questions facing companies employing single-use technologies for commercial manufacturing.
|
|
|
|
| |
